Belgium is reviewing Apple’s iPhone 12 after France decided to halt sales of the handset, saying it breached radiation exposure limits, while Germany announced that the French iPhone 12 process will guide Europe in terms of measures it may need to take.

Belgium announced today that it will look into potential health risks linked to Apple’s iPhone 12.

The day before yesterday, Tuesday, the French National Agency for Frequencies (ANFR) asked Apple to stop sales of the iPhone 12 in France after tests showed that the phone’s Specific Absorption Rate (SAR) – an indicator of the rate at which radio frequency radiation is absorbed by tissues of the human body- is higher than allowed.

Apple announced yesterday, Wednesday, that the iPhone 12, which was released in 2020, has been certified by several international organizations as complying with radiation standards, and that the company disputes France’s findings.

But Paris’ move to halt sales of the iPhone 12 until Apple fixes radiation issues found in two tests raises the prospect of further bans in Europe.

“It is my duty to ensure that all citizens … are safe,” Mathieu Michel, Belgium’s undersecretary for Digitization, said in a statement.

“I quickly reached out to the IBPT-BIPT (regulatory authority) to request an analysis of potential risks from the product,” Michel said, adding that he also asked the regulator to look at all Apple smartphones at a later stage, as and devices from other manufacturers.

In addition, Germany’s competent regulatory authority announced today that it will review the iPhone 12 radiation concerns for the German market when France’s investigation is sufficiently advanced and added that the process in France will guide Europe as a whole.

“The relevant German federal agency is in close contact with the competent authority in France,” the German regulator told Reuters.